featured
Guadecitabine Combined With Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined With Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)
Clin. Cancer Res 2021 Jan 20;[EPub Ahead of Print], SJ Crabb, S Danson, JWF Catto, S Hussain, D Chan, D Dunkley, N Downs, E Marwood, L Day, GN Saunders, M Light, A Whitehead, DJ Ellis, N Sarwar, D Enting, AJ Birtle, B Johnson, R Huddart, G GriffithsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.